G12.21
BillableAmyotrophic lateral sclerosis
HCC Category Mapping
What This Code Means
Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that causes muscle weakness and paralysis by damaging nerve cells that control voluntary muscles. This condition gradually worsens over time and affects a person's ability to move, speak, eat, and breathe.
Coding Tips
- •ALS is a chronic progressive condition; ensure documentation clearly supports the diagnosis and specify the stage or severity if documented (onset, progression, affected body regions)
- •Code G12.21 is specific to ALS; do not confuse with other motor neuron diseases coded under G12.2x (such as progressive muscular atrophy G12.25 or primary lateral sclerosis G12.29)
Clinical Significance
Amyotrophic lateral sclerosis is one of the most devastating neurodegenerative diseases, causing progressive paralysis and death typically within 3-5 years of diagnosis. It involves both upper and lower motor neuron degeneration and drives extremely high healthcare costs including ventilator support, feeding tubes, communication devices, and expensive medications like riluzole and edaravone.
Documentation Requirements
- ✓El Escorial criteria or equivalent diagnostic criteria documented
- ✓Both upper motor neuron signs (spasticity, hyperreflexia) and lower motor neuron signs (atrophy, fasciculations) present
- ✓Electromyography findings consistent with widespread denervation
- ✓Rate of disease progression and affected body regions
- ✓Current respiratory function (forced vital capacity)
- ✓Treatment with disease-modifying medications (riluzole, edaravone, tofersen) if applicable